Literature DB >> 26475869

Plasticity beyond cancer cells and the "immunosuppressive switch".

Zvi Granot1, Zvi G Fridlender2.   

Abstract

Tumor initiation, growth, and metastatic progression are complex processes that, in order to be successful, require extraordinary cellular plasticity. Accordingly, tumor cell plasticity and how it affects disease progression have been studied extensively. However, as our understanding of the tumor microenvironment deepens, we are confronted with the notion that functional plasticity in the context of cancer is not limited to tumor cells alone but is also commonly seen in normal stromal cells of the microenvironment, and specifically in immune cells. Here, we review the functional plasticity these cells exhibit in the context of cancer, highlighting the role of circulating and tumor-associated neutrophils. We further discuss how this plasticity supports or limits tumor progression, inducing an "immunosuppressive switch" to promote further tumor growth and development. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 26475869     DOI: 10.1158/0008-5472.CAN-15-1502

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  32 in total

1.  Neutrophil Cathepsin G and Tumor Cell RAGE Facilitate Neutrophil Anti-Tumor Cytotoxicity.

Authors:  Ronit Vogt Sionov; Tanya Fainsod-Levi; Tamir Zelter; Lola Polyansky; Christine T Pham; Zvi Granot
Journal:  Oncoimmunology       Date:  2019-06-11       Impact factor: 8.110

Review 2.  Mouse versus Human Neutrophils in Cancer: A Major Knowledge Gap.

Authors:  Evgeniy B Eruslanov; Sunil Singhal; Steven M Albelda
Journal:  Trends Cancer       Date:  2017-01-19

3.  Heme oxygenase-1 orchestrates the immunosuppressive program of tumor-associated macrophages.

Authors:  Emmanuelle Alaluf; Benoît Vokaer; Aurélie Detavernier; Abdulkader Azouz; Marion Splittgerber; Alice Carrette; Louis Boon; Frédérick Libert; Miguel Soares; Alain Le Moine; Stanislas Goriely
Journal:  JCI Insight       Date:  2020-06-04

4.  Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer.

Authors:  Sunil Singhal; Pratik S Bhojnagarwala; Shaun O'Brien; Edmund K Moon; Alfred L Garfall; Abhishek S Rao; Jon G Quatromoni; Tom Li Stephen; Leslie Litzky; Charuhas Deshpande; Michael D Feldman; Wayne W Hancock; Jose R Conejo-Garcia; Steven M Albelda; Evgeniy B Eruslanov
Journal:  Cancer Cell       Date:  2016-06-30       Impact factor: 31.743

Review 5.  Phenotype and function of tumor-associated neutrophils and their subsets in early-stage human lung cancer.

Authors:  Evgeniy B Eruslanov
Journal:  Cancer Immunol Immunother       Date:  2017-03-10       Impact factor: 6.968

Review 6.  Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal.

Authors:  Kelly L Singel; Brahm H Segal
Journal:  Immunol Rev       Date:  2016-09       Impact factor: 12.988

7.  Tumor-associated neutrophils display a distinct N1 profile following TGFβ modulation: A transcriptomics analysis of pro- vs. antitumor TANs.

Authors:  Merav E Shaul; Liran Levy; Jing Sun; Inbal Mishalian; Sunil Singhal; Veena Kapoor; Wenhwai Horng; Gil Fridlender; Steven M Albelda; Zvi G Fridlender
Journal:  Oncoimmunology       Date:  2016-09-13       Impact factor: 8.110

Review 8.  Immune Regulation of the Metastatic Process: Implications for Therapy.

Authors:  A de Mingo Pulido; B Ruffell
Journal:  Adv Cancer Res       Date:  2016-06-17       Impact factor: 6.242

Review 9.  Neutrophil diversity and plasticity in tumour progression and therapy.

Authors:  Sebastien Jaillon; Andrea Ponzetta; Diletta Di Mitri; Angela Santoni; Raffaella Bonecchi; Alberto Mantovani
Journal:  Nat Rev Cancer       Date:  2020-07-21       Impact factor: 60.716

Review 10.  Immune and regulatory functions of neutrophils in inflammatory bone loss.

Authors:  George Hajishengallis; Niki M Moutsopoulos; Evlambia Hajishengallis; Triantafyllos Chavakis
Journal:  Semin Immunol       Date:  2016-02-28       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.